These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23402185)

  • 1. [Treatment of chronic viral hepatitis: achievements and prospects].
    Golovanova EV
    Eksp Klin Gastroenterol; 2012; (6):3-12. PubMed ID: 23402185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V; Mise S
    Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
    Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
    Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
    Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
    HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrosis in chronic viral hepatitis.
    Calvaruso V; Craxì A
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):219-30. PubMed ID: 21497740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies.
    Poynard T; Ngo Y; Munteanu M; Thabut D; Massard J; Moussalli J; Varaud A; Benhamou Y; Ratziu V
    Antivir Ther; 2010; 15(4):617-31. PubMed ID: 20587855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hepatology].
    Mondada D; Pache I; Leopold K; Thorens J; Moradpour D; Gonvers JJ
    Rev Med Suisse; 2006 Jan; 2(49):218-20, 223-6, 228-30. PubMed ID: 16493965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Computerized histological analysis in chronic viral hepatitis].
    Hassan C; Tavani PD; Serafini B
    Pathologica; 1999 Jun; 91(3):173-8. PubMed ID: 10536462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B-associated fibrosis and fibrosis/cirrhosis regression with nucleoside and nucleotide analogs.
    Brown A; Goodman Z
    Expert Rev Gastroenterol Hepatol; 2012 Apr; 6(2):187-98. PubMed ID: 22375524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological response to interferon alfa-based therapies in hepatitis C.
    Lee SS
    Semin Liver Dis; 2004; 24 Suppl 2():55-60. PubMed ID: 15346247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathology of chronic hepatitis B and chronic hepatitis C.
    Fiel MI
    Clin Liver Dis; 2010 Nov; 14(4):555-75. PubMed ID: 21055682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of chronic hepatitis B and C virus infections in the clinical practice].
    Panther E; Thimme R
    Praxis (Bern 1994); 2012 Jan; 101(1):37-42. PubMed ID: 22219073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of HBV-related cirrhosis.
    Vallet-Pichard A; Mallet V; Costentin CE; Pol S
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease.
    Cacciola I; Pollicino T; Squadrito G; Cerenzia G; Orlando ME; Raimondo G
    N Engl J Med; 1999 Jul; 341(1):22-6. PubMed ID: 10387938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural leukocyte interferon alfa for the treatment of chronic viral hepatitis in heart transplant recipients.
    Fagiuoli S; Pevere S; Minniti F; Livi U; Caforio AL; Naccarato R; Chiaramonte M
    Transplantation; 2003 Apr; 75(7):982-6. PubMed ID: 12698084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natural history, diagnosis and treatment of chronic hepatitis B and C in hemodialysis patients].
    Nicolardi E; Grieco A; Rapaccini GL; Pompili M
    G Ital Nefrol; 2010; 27(3):262-73. PubMed ID: 20540019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.